Severe Hypertension: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 10: | Line 10: | ||
'''[[Initial Medical Assessment and Care|INITIAL MEDICAL CARE]] (2.01) - [[ | '''[[Initial Medical Assessment and Care|INITIAL MEDICAL CARE]] (2.01) - [[Oxygen|OXYGEN]] only if SaO2 < 95%''' | ||
* Immediate Transport | * Immediate Transport | ||
* Monitor and document BP every 5 minutes | * Monitor and document BP every 5 minutes | ||
'''Treat symptoms:''' | '''Treat symptoms:''' | ||
* IF patient is vomiting or has severe nausea, administer | * IF patient is vomiting or has severe nausea, administer [[Promethazine|PROMETHAZINE]] OR [[Zofran|ZOFRAN]] as appropriate. | ||
* IF Chest Pain refer to [[Chest Pain Acute Coronary Syndrome|CHEST PAIN / ACUTE CORONARY SYNDROME]] (4.01) | * IF Chest Pain refer to [[Chest Pain Acute Coronary Syndrome|CHEST PAIN / ACUTE CORONARY SYNDROME]] (4.01) | ||
* [[ | * [[Morphine_Sulfate|MORPHINE SULFATE]] 2-20 mg titrated to effect. | ||
* IF Neurological deficits refer to [[Suspected Stroke Transcient Ischemic Attack TIA|STROKE PRACTICE PARAMETER]] (5.04) | * IF Neurological deficits refer to [[Suspected Stroke Transcient Ischemic Attack TIA|STROKE PRACTICE PARAMETER]] (5.04) | ||
[[Category:Medical|0509]] | [[Category:Medical|0509]] | ||
Latest revision as of 14:35, 24 April 2020
Section 5 -MEDICAL
5.09 SEVERE HYPERTENSION
(Systolic BP > 230 mm Hg and/or Diastolic BP > 120 mm Hg)
CONSIDER MEDICAL ETIOLOGY OF HYPERTENSIVE CRISIS AND REFER TO APPROPRIATE PRACTICE PARAMETER:
- PULMONARY EDEMA (4.11)
- CHEST PAIN / ACUTE CORONARY SYNDROME (4.01)
- STROKE PRACTICE PARAMETER (5.04)
INITIAL MEDICAL CARE (2.01) - OXYGEN only if SaO2 < 95%
- Immediate Transport
- Monitor and document BP every 5 minutes
Treat symptoms:
- IF patient is vomiting or has severe nausea, administer PROMETHAZINE OR ZOFRAN as appropriate.
- IF Chest Pain refer to CHEST PAIN / ACUTE CORONARY SYNDROME (4.01)
- MORPHINE SULFATE 2-20 mg titrated to effect.
- IF Neurological deficits refer to STROKE PRACTICE PARAMETER (5.04)